¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22
±³À°ÀÏÀÚ : 2024-06-22
±³À°Àå¼Ò : ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±ÝȦ

±³À°ÁÖÁ¦ : Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ

ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹ÃéÀå¿Ü°úÇÐȸ

´ã´çÀÚ : õÇöÁÖ
¿¬¶ôó : 02-0000-0000

À̸ÞÀÏ : kpsc2004@gmail.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ÀüºÏƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í Àüü Âü°¡ÀÚ 50000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 09:00~09:20 Neoadjuvant chemotherapy for resectable pancreatic cancer - current status ±è±ÔÇ¥(¿ï»êÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 09:20~09:40 The resectability of pancreatic cancer after neoadjuvant treatment: a radiological perspective ÇѽÂö(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 09:40~10:00 Histopathological tumor response scoring in resected pancreatic cancer following neoadjuvant therapy ÀÌ°æºÐ(¼­¿ïÀÇ´ë º´¸®°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 10:00~10:20 Impact of surgical resection after preoperative chemotherapy for metastatic pancreatic cancer Ȳȣ°æ(¿¬¼¼ÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 10:20~10:40 Discussion È«½Â¼ö(¿¬¼¼ÀÇ´ë ¿Ü°ú)

ÈÞ½Ä 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 10:40~10:50 Coffee break ()

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 10:50~11:10 Clinical utility of NGS(Next generation sequencing) panel in pancreato-biliary cancers À̼ºÈ¯(Â÷ÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:10~11:20 Discussion À±¿ø°Ç(¼­¿ïÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:20~11:30 ±¸¿¬ ¹ßÇ¥)Role of adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas after surgical resection: Korean multicenter study ÃÖ¹®¼®(¿¬¼¼ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:30~11:40 ±¸¿¬ ¹ßÇ¥)Analysis of the effects of probiotics intake on the microbiome of bile and feces in patients with chronic cholecystitis for the treatment of future biliary tract cancer; single center, single arm, prospective clinical trial ±è¼®È¯(Ãæ³²ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:40~11:50 ±¸¿¬ ¹ßÇ¥)Cost-effectiveness analysis of the revised International Association of Pancreatology (IAP) 2023 guidelines for the management of branch-duct intraductal papillary mucinous neoplasm Á¤Çý¼Ö(¼­¿ïÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:50~12:00 ±¸¿¬ ¹ßÇ¥)The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy: A Multicenter, Randomized, Controlled Trial ¹Ú¼ºÀº(°¡Å縯ÀÇ´ë ¿Ü°ú)

½Ä»ç 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 12:00~13:00 Lunch ()

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 13:00~13:30 Surgical tips for advanced pancreatic cancer in open surgery ±è¼Ûö(¿ï»êÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 13:30~13:50 Discussion º¯À±Çü(À»ÁöÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 13:50~14:10 Updated guidelines for pancreatic cyst surveillance ÃÖ»õº°(°í·ÁÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 14:10~14:30 Repeated pancreatectomy vs. chemotherapy for isolated local recurrence of pancreatic cancer in remnant pancreas ÇÑÀοõ(¼º±Õ°üÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 14:30~14:50 Borderline resectable bile duct cancer: chemotherapy first vs. surgery first ¾ç¼®Á¤(Â÷ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 14:50~15:10 Fee for Hepatobiliary andpancreatic surgery in the National Health Insurance System ¼º¹Î±Ô(¿ï»êÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 15:10~15:30 Discussion ¼ÕÈñÁÖ(Áß¾ÓÀÇ´ë ¿Ü°ú)

ÈÞ½Ä 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 15:30~15:40 Coffee break ()

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 15:40~15:55 If the Right hepatic artery has to be completely occluded after artery reconstruction for surgery of perihilar cholangiocarcinoma IIIb, what will happen next in remnant liver? ÀÌÀçÈÆ(¿ï»êÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 15:55~16:10 Incidental high-grade dysplasia of the cystic duct and margin involvement: Watch and wait or Extensive surgery ¼ÕÈñÁÖ(Áß¾ÓÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 16:10~16:25 Pseudoaneurysm after pylorus-preserving pancreaticoduodenectomy (PPPD), is there no other way? À¯¼¼Çö(°í·ÁÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 16:25~16:40 Diffuse bile duct cancer portal vein & proper hepatic artery invasion ÀÌÁ¤¿ì(ÇѸ²ÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 16:40~17:00 Discussion ±è¼ºÇö(¿¬¼¼ÀÇ´ë ¿Ü°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22
´ÙÀ½±Û ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
62 ¼­¿ï 2018 ÇÏ°è ºÐÀÚÆó¾Ï¿¬±¸È¸ Àӻ󿬱¸ ¿öÅ©¼ó : 2018-08-18 0 550 2018-07-28
61 ¼­¿ï ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ÃÊÀ½ÆÄ °Ë»ç ±Ç°í¾È ½ÉÆ÷Áö¾ö : 2018-08-18 0 777 2018-07-28
60 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-18 0 679 2018-07-28
59 ¼­¿ï ´ëÇÑ»êºÎÀΰúÀÇ»çȸ&Çѱ¹¹ß»ý»ý¹°ÇÐȸ Joint Symposium : 2018-08-18 0 1,082 2018-07-28
58 ¼­¿ï ´ëÇѺ´¸®ÇÐȸ 8th Ç÷¾×º´¸® ¿¬¼ö±³À° : 2018-08-18 0 739 2018-07-28
57 ¼­¿ï ´ëÇѴٹ߼º°æÈ­ÁõÇÐȸ 2018³â ¿¬·ÊÇмú´ëȸ : 2018-08-18 0 845 2018-07-28
56 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ 2018³âµµ Á¦2Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2018-08-17 0 858 2018-07-28
55 °­¿ø ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2018-08-17 0 1,287 2018-07-28
54 ¼­¿ï Á߾Ӵ뺴¿ø »êºÎÀΰú žÆÃÊÀ½ÆÄ ¿¬¼Ó°­Á : 2018-08-16 0 661 2018-07-28
53 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À°(ÈĵÎÁúȯ) : 2018-08-16 0 730 2018-07-28
52 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè ¼ö°¡°áÁ¤ : 2018-08-16 0 868 2018-07-28
51 ¼­¿ï Çѱ¹¿ªÇÐȸ Biomarker ¸¦ ÀÌ¿ëÇÑ ¿¬±¸ ¼³°è¿Í ºÐ¼® : 2018-08-14 0 1,279 2018-07-28
50 ¼­¿ï Á¦240ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ : 2018-08-14 0 426 2018-07-28
49 ¼­¿ï Çѱ¹¿ªÇÐȸ MR ±â¹Ý À¯Àüü ¿ªÇבּ¸¿Í °ø°ø°Ç°­ÀÚ·á ±â¹Ý Outcome research : 2018-08-13 0 653 2018-07-28
48 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø 2018 Catholic Orthopedic Symposium II - Foot & Ankle, Hip, Knee - : 2018-08-12 0 1,105 2018-07-28
1411 | 1412 | 1413 | 1414 | 1415
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷